Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis

Laura B Nellums, Hayley Thompson, Alison Holmes, Enrique Castro-Sánchez, Jonathan A Otter, Marie Norredam, Jon S Friedland, Sally Hargreaves, Laura B Nellums, Hayley Thompson, Alison Holmes, Enrique Castro-Sánchez, Jonathan A Otter, Marie Norredam, Jon S Friedland, Sally Hargreaves

Abstract

Background: Rates of antimicrobial resistance (AMR) are rising globally and there is concern that increased migration is contributing to the burden of antibiotic resistance in Europe. However, the effect of migration on the burden of AMR in Europe has not yet been comprehensively examined. Therefore, we did a systematic review and meta-analysis to identify and synthesise data for AMR carriage or infection in migrants to Europe to examine differences in patterns of AMR across migrant groups and in different settings.

Methods: For this systematic review and meta-analysis, we searched MEDLINE, Embase, PubMed, and Scopus with no language restrictions from Jan 1, 2000, to Jan 18, 2017, for primary data from observational studies reporting antibacterial resistance in common bacterial pathogens among migrants to 21 European Union-15 and European Economic Area countries. To be eligible for inclusion, studies had to report data on carriage or infection with laboratory-confirmed antibiotic-resistant organisms in migrant populations. We extracted data from eligible studies and assessed quality using piloted, standardised forms. We did not examine drug resistance in tuberculosis and excluded articles solely reporting on this parameter. We also excluded articles in which migrant status was determined by ethnicity, country of birth of participants' parents, or was not defined, and articles in which data were not disaggregated by migrant status. Outcomes were carriage of or infection with antibiotic-resistant organisms. We used random-effects models to calculate the pooled prevalence of each outcome. The study protocol is registered with PROSPERO, number CRD42016043681.

Findings: We identified 2274 articles, of which 23 observational studies reporting on antibiotic resistance in 2319 migrants were included. The pooled prevalence of any AMR carriage or AMR infection in migrants was 25·4% (95% CI 19·1-31·8; I2 =98%), including meticillin-resistant Staphylococcus aureus (7·8%, 4·8-10·7; I2 =92%) and antibiotic-resistant Gram-negative bacteria (27·2%, 17·6-36·8; I2 =94%). The pooled prevalence of any AMR carriage or infection was higher in refugees and asylum seekers (33·0%, 18·3-47·6; I2 =98%) than in other migrant groups (6·6%, 1·8-11·3; I2 =92%). The pooled prevalence of antibiotic-resistant organisms was slightly higher in high-migrant community settings (33·1%, 11·1-55·1; I2 =96%) than in migrants in hospitals (24·3%, 16·1-32·6; I2 =98%). We did not find evidence of high rates of transmission of AMR from migrant to host populations.

Interpretation: Migrants are exposed to conditions favouring the emergence of drug resistance during transit and in host countries in Europe. Increased antibiotic resistance among refugees and asylum seekers and in high-migrant community settings (such as refugee camps and detention facilities) highlights the need for improved living conditions, access to health care, and initiatives to facilitate detection of and appropriate high-quality treatment for antibiotic-resistant infections during transit and in host countries. Protocols for the prevention and control of infection and for antibiotic surveillance need to be integrated in all aspects of health care, which should be accessible for all migrant groups, and should target determinants of AMR before, during, and after migration.

Funding: UK National Institute for Health Research Imperial Biomedical Research Centre, Imperial College Healthcare Charity, the Wellcome Trust, and UK National Institute for Health Research Health Protection Research Unit in Healthcare-associated Infections and Antimictobial Resistance at Imperial College London.

Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Figures

Figure 1
Figure 1
Study selection
Figure 2
Figure 2
Distribution of antibiotic-resistant organisms among migrants by country of origin MRSA=meticillin-resistant Staphylococcus aureus.
Figure 3
Figure 3
Pooled prevalence of antibiotic resistance among migrants to Europe AMR=antimicrobial resistance.
Figure 4
Figure 4
Pooled prevalence of antibiotic resistance by migrant type Prevalence among refugees and asylum seekers (A) and among other migrants (B). AMR=antimicrobial resistance.
Figure 5
Figure 5
Pooled prevalence of antibiotic resistance by setting Prevalence in high-migrant settings (A) and in hospital settings (B). AMR=antimicrobial resistance.

References

    1. Nature The antibiotic alarm. Nature. 2013;495:141.
    1. WHO Global action plan on antimicrobial resistance. 2015.
    1. Gandra S, Barter D, Laxminarayan R. Economic burden of antibiotic resistance: how much do we really know? Clin Microbiol Infect. 2014;20:973–980.
    1. European Centre for Disease Prevention and Control/European Medicines Agency Joint Working Group The bacterial challenge: time to react.
    1. Falagas ME, Tansarli GS, Karageorgopoulos DE, Vardakas KZ. Deaths attributable to carbapenem-resistant Enterobacteriaceae infections. Emerg Infect Dis. 2014;20:1170–1175.
    1. WHO Antimicrobial resistance: global report on surveillance 2014. April, 2014.
    1. Laxminarayan R, Duse A, Wattal C. Antibiotic resistance—the need for global solutions. Lancet Infect Dis. 2013;13:1057–1098.
    1. European Centre for Disease Prevention and Control Annual epidemiological report 2014. Antimicrobial resistance and healthcare-associated infections.
    1. Holmes AH, Moore LS, Sundsfjord A. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet. 2016;387:176–187.
    1. van der Bij AK, Pitout JD. The role of international travel in the worldwide spread of multiresistant Enterobacteriaceae. J Antimicrob Chemother. 2012;67:2090–2100.
    1. WHO Migration and health: key issues. 2016.
    1. Maltezou HC. Antibiotic resistance and the refugee crisis in Europe–preemptive action is indicated. Travel Med Infect Dis. 2016;14:69–70.
    1. Auguet OT, Betley JR, Stabler RA. Evidence for community transmission of community-associated but not health-care-associated methicillin-resistant Staphylococcus aureus strains linked to social and material deprivation: spatial analysis of cross-sectional data. PLoS Med. 2016;13:e1001944.
    1. Public Health England English surveillance programme for antimicrobial utilisation and resistance (ESPAUR). Report 2016.
    1. Eurostat Migration and migrant population statistics. 2015.
    1. International Organization for Migration EU migrant, refugee arrivals by land and sea approach one million in 2015. Dec 18, 2015.
    1. Lillebaek T, Andersen AB, Dirksen A, Smith E, Skovgaard LT, Kok-Jensen A. Persistent high incidence of tuberculosis in immigrants in a low-incidence country. Emerg Infect Dis. 2002;8:679–684.
    1. Cousins S. Syrian crisis: health experts say more can be done. Lancet. 2015;385:931–934.
    1. Mahfoud M, Al Najjar M, Hamzeh AR. Multidrug resistance in Pseudomonas aeruginosa isolated from nosocomial respiratory and urinary infections in Aleppo, Syria. J Infect Dev Ctries. 2015;9:210–213.
    1. UNHCR Refugees/migrants emergency response—Mediterranean. 2016.
    1. WHO Worldwide country situation analysis: response to antimicrobial resistance. 2015.
    1. Hargreaves S, Nellums L, Friedland J, Goldberg J, PMurwill P, Jones L. Extending migrant charging into emergency services. BMJ. 2016;352:i685.
    1. European Centre for Disease Prevention and Control Systematic review of the effectiveness of infection control measures to prevent the transmission of carbapenemase-producing Enterobacteriaceae through cross-border transfer of patients. 2014.
    1. Aiken AM, Allegranzi B, Scott JA, Mehtar S, Pittet D, Grundmann H. Antibiotic resistance needs global solutions. Lancet Infect Dis. 2014;14:550–551.
    1. MacPherson DW, Gubbins PO, Holtom P, Segarra-Newnham M. Population mobility, globalisation, and antimicrobial drug resistance. In: Choffnes ER, Relman DA, Mack A, editors. Antibiotic resistance: implications for global health and novel intervention strategies: workshop summary. National Academies Press; Washington, DC: 2010. p. 35.
    1. Memish ZA, Venkatesh S, Shibl AM. Impact of travel on international spread of antimicrobial resistance. Int J Antimicrob Agents. 2003;21:135–142.
    1. Cook DJ, Mulrow CD, Haynes RB. Systematic reviews: synthesis of best evidence for clinical decisions. Ann Intern Med. 1997;126:376–380.
    1. Liberati A, Altman DG, Tetzlaff J. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6:e1000100.
    1. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264–269.
    1. Klinkenberg E, Manissero D, Semenza J, Verver S. Migrant tuberculosis screening in the EU/EEA: yield, coverage and limitations. Eur Respir J. 2009;34:1180–1189.
    1. Tomás BA, Pell C, Cavanillas AB, Solvas JG, Pool R, Roura M. Tuberculosis in migrant populations. A systematic review of the qualitative literature. PLoS One. 2013;8:e82440.
    1. Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ. 2010;340:c2096.
    1. Galán Montemayor JC, Moreno Bofarull A, Baquero Mochales F. Impacto de los movimientos migratorios en la resistencia bacteriana a los antibióticos. Rev Esp Salud Publica. 2014;88:829–837.
    1. Oxman AD, Group GW. Grading quality of evidence and strength of recommendations. BMJ. 2004;328:1490–1494.
    1. Wells G, Shea B, O'Connell D. Ottawa Hospital Research Institute; Ottawa, ON: 2011. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses.
    1. Higgins JP, Altman DG, Gøtzsche PC. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
    1. Nyaga VN, Arbyn M, Aerts M. Metaprop: a Stata command to perform meta-analysis of binomial data. Arch Public Health. 2014;72:1.
    1. Sterne JA, Bradburn MJ, Egger M. Meta-analysis in Stata. In: Egger M, Davey-Smith G, Douglas Altman D, editors. Systematic reviews in health care: meta-analysis in context. 2nd edn. BMJ Books; London: 2008. pp. 347–369.
    1. Angeletti S, Ceccarelli G, Vita S. Unusual microorganisms and antimicrobial resistances in a group of Syrian migrants: sentinel surveillance data from an asylum seekers centre in Italy. Travel Med Infect Dis. 2016;14:115–122.
    1. Broseta A, Chaves F, Rojo P, Otero J. Emergence of a single clone of community-associated methicillin-resistant Staphylococcus aureus in southern Madrid children. Enferm Infecc Microbiol Clin. 2006;24:31–35. (in Spanish).
    1. Casado-Verrier B, Gómez-Fernández C, Pano-Pardo JR. Prevalencia de infecciones de piel y tejidos blandos producidas por Staphylococcus aureus resistente a meticilina comunitario en Madrid. Enferm Infecc Microbiol Clín. 2012;30:300–306.
    1. Cercenado E, Cuevas O, Marín M. Community-acquired methicillin-resistant Staphylococcus aureus in Madrid, Spain: transcontinental importation and polyclonal emergence of Panton–Valentine leukocidin-positive isolates. Diagn Microbiol Infect Dis. 2008;61:143–149.
    1. Dudareva S, Barth A, Paeth K. Cases of community-acquired meticillin-resistant Staphylococcus aureus in an asylum seekers centre in Germany, November 2010. Euro Surveill. 2011;16:19777.
    1. Frick MA, Moraga-Llop FA, Bartolomé R. Infecciones por Staphylococcus aureus resistente a meticilina adquirido en la comunidad en niños. Enferm Infecc Microbiol Clín. 2010;28:675–679.
    1. Georgakopoulou T, Mandilara G, Mellou K. Resistant shigella strains in refugees, August–October 2015, Greece. Epidemiol Infect. 2016;144:2415–2419.
    1. Gustafsson E, Ringberg H, Johansson P. MRSA in children from foreign countries adopted to Swedish families. Acta Paediatr. 2007;96:105–108.
    1. Hagleitner MM, Mascini EM, van Berkel S, Bosman J, Mulder JC, van Setten PA. Foreign adopted children are a source of methicillin-resistant Staphylococcus aureus transmission to countries with low prevalence. Pediatr Infect Dis J. 2012;31:655–658.
    1. Heudorf U, Krackhardt B, Karathana M, Kleinkauf N, Zinn C. Multidrug-resistant bacteria in unaccompanied refugee minors arriving in Frankfurt am Main, Germany, October to November 2015. Euro Surveill. 2016;21:30109.
    1. Heudorf U, Albert-Braun S, Hunfeld K-P. Multidrug-resistant organisms in refugees: prevalences and impact on infection control in hospitals. GMS Hyg Infect Control. 2016;11:Doc16.
    1. Krüger C, Schuler-Lüttmann S, Haug T, Gantert M, Hermsen M. Multidrug-resistant bacteria in refugee children and pregnant women admitted to a general hospital in North Rhine-Westphalia, Germany. Klin Pädiatr. 2016;228:227–229.
    1. Lederer I, Taus K, Allerberger F. Shigellosis in refugees, Austria, July to November 2015. Euro Surveill. 2015;20:30081.
    1. Manzur A, Dominguez A, Pujol M. Community-acquired methicillin-resistant Staphylococcus aureus infections: an emerging threat in Spain. Clin Microbiol Infect. 2008;14:377–380.
    1. Marschall J, Dürig P, Mühlemann K. Low prevalence of methicillin-resistant Staphylococcus aureus (MRSA) carriage in women from former Yugoslavia living in Switzerland. Eur J Clinl Microbiol Infect Dis. 2006;25:535–536.
    1. Oliva A, Lichtner M, Mascellino M. Study of methicillin-resistant Staphylococcus aureus (MRSA) carriage in a population of HIV-negative migrants and HIV-infected patients attending an outpatient clinic in Rome. Ann Ig. 2012;25:99–107.
    1. Piso RJ, Kach R, Pop R. A cross-sectional study of colonization rates with methicillin-resistant Staphylococcus aureus (MRSA) and extended-spectrum beta-lactamase (ESBL) and carbapenemase-producing Enterobacteriaceae in four Swiss refugee centres. PLoS One. 2017;12:e0170251.
    1. Ravensbergen SJ, Lokate M, Cornish D. High prevalence of infectious diseases and drug-resistant microorganisms in asylum seekers admitted to hospital; no carbapenemase producing Enterobacteriaceae until September 2015. PLoS One. 2016;11:e0154791.
    1. Reinheimer C, Kempf V, Göttig S. Multidrug-resistant organisms detected in refugee patients admitted to a University Hospital, Germany June December 2015. Euro Surveill. 2016;21:30110.
    1. Steger S, Demetz F, Schmidt C, Borgmann S. Low percentage of asylum seekers colonized with multi-resistant bacteria treated at a German hospital. Jacobs J Epidemiol Prev Med. 2016;2:021.
    1. Stenhem M, Ortqvist A, Ringberg H. Imported methicillin-resistant Staphylococcus aureus, Sweden. Emerg Infect Dis. 2010;16:189–196.
    1. Tenenbaum T, Becker K-P, Lange B. Prevalence of multidrug-resistant organisms in hospitalized pediatric refugees in an University Children's Hospital in Germany 2015–2016. Infect Control Hosp Epidemiol. 2016;37:1310–1314.
    1. Valverde A, Turrientes M-C, Norman F. CTX-M-15-non-ST131 Escherichia coli isolates are mainly responsible of faecal carriage with ESBL-producing Enterobacteriaceae in travellers, immigrants and those visiting friends and relatives. Clin Microbiol Infect. 2015;21:e1–e4.
    1. Boyle-Vavra S, Daum RS. Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton–Valentine leukocidin. Lab Invest. 2007;87:3–9.
    1. Otter J, Kearns A, French G, Ellington M. Panton–Valentine leukocidin-encoding bacteriophage and gene sequence variation in community-associated methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect. 2010;16:68–73.
    1. European Centre for Disease Prevention and Control Surveillance Atlas of Infectious Diseases. 2015.
    1. Woerther P-L, Burdet C, Chachaty E, Andremont A. Trends in human fecal carriage of extended-spectrum β-lactamases in the community: toward the globalization of CTX-M. Clin Microbiol Rev. 2013;26:744–758.
    1. Connolly MA, Gayer M, Ryan MJ, Salama P, Spiegel P, Heymann DL. Communicable diseases in complex emergencies: impact and challenges. Lancet. 2004;364:1974–1983.
    1. European Centre for Disease Prevention and Control . European Centre for Disease Prevention and Control; Stockholm: 2015. Antimicrobial resistance surveillance in Europe 2014: Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net)
    1. Otter J, French G. The emergence of community-associated methicillin-resistant Staphylococcus aureus at a London teaching hospital, 2000–2006. Clin Microbiol Infect. 2008;14:670–676.
    1. Angeletti S, Cella E, Lai A. Whole-genome sequencing of Klebsiella pneumoniae MDR strain isolated in a Syrian refugee. Pathog Glob Health. 2017;111:212–215.
    1. European Centre for Disease Prevention and Control . European Centre for Disease Prevention and Control; Stockholm: 2014. Assessing the burden of key infectious diseases affecting migrant populations in the EU/EEA.
    1. European Centre for Disease Prevention and Control . European Centre for Disease Prevention and Control; Stockholm: 2015. Rapid risk assessment: communicable disease risks associated with the movement of refugees in Europe during the winter season.
    1. Public Health England Acute trust toolkit for the early detection, management and control of carbapenemase-producing Enterobacteriaceae. 2013.
    1. Tacconelli E, Cataldo M, Dancer S. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect. 2014;20:1–55.
    1. Reinheimer C, Kempf VA, Jozsa K. Prevalence of multidrug-resistant organisms in refugee patients, medical tourists and domestic patients admitted to a German university hospital. BMC Infect Dis. 2017;17:17.
    1. Walter J, Haller S, Hermes J, Arvand M, Sin MA, Eckmanns T. Letter to the editor: Is there a need for special treatment of refugees at hospital admission? Euro Surveill. 2016;21:30137.
    1. Seybold U, Wagener J, Jung J, Sammet S. Multidrug-resistant organisms among refugees in Germany: we need evidence-based care, not fear-based screening. J Hosp Infect. 2016;92:229–231.
    1. Leblebicioglu H, Rodriguez-Morales AJ, Rossolini GM, López-Vélez R, Zahar J-R, Rello J. Management of infections in critically ill returning travellers in the intensive care unit—I: considerations on infection control and transmission of resistance. Int J Infect Dis. 2016;48:113–117.
    1. Tornimbene B, Eremin S, Escher M, Griskeviciene J, Manglani S, Pessoa-Silva CL. WHO Global Antimicrobial Resistance Surveillance System early implementation 2016–17. Lancet Infect Dis. 2018;18:241–242.
    1. WHO . World Health Organization; Geneva: 2017. Promoting the health of refugees and migrants: draft gramework of priorities and guiding principles to promote the health of refugees and migrants.
    1. Rechel B, Mladovsky P, Ingleby D, Mackenbach JP, McKee M. Migration and health in an increasingly diverse Europe. Lancet. 2013;381:1235–1245.
    1. Lillebaek T, Andersen AB, Dirksen A, Smith E, Skovgaard LT, Kok-Jensen A. Persistent high incidence of tuberculosis in immigrants in a low-incidence country. Emerg Infect Dis. 2002;8:679–684.
    1. Lillebaek T, Andersen ÅB, Bauer J. Risk of Mycobacterium tuberculosis transmission in a low-incidence country due to immigration from high-incidence areas. J Clin Microbiol. 2001;39:855–861.
    1. Dahle UR, Sandven P, Heldal E, Caugant DA. Continued low rates of transmission of Mycobacterium tuberculosis in Norway. J Clin Microbiol. 2003;41:2968–2973.
    1. Kamper-Jørgensen Z, Andersen AB, Kok-Jensen A. Migrant tuberculosis: the extent of transmission in a low burden country. BMC Infect Dis. 2012;12:1.
    1. Stich A. Frequent infectious diseases in migrants. Der Internist. 2016;57:409–415.
    1. Blaya JA, Fraser HS, Holt B. E-health technologies show promise in developing countries. Health Affairs. 2010;29:244–251.
    1. Mendelson M, Røttingen J-A, Gopinathan U. Maximising access to achieve appropriate human antimicrobial use in low-income and middle-income countries. Lancet. 2016;387:188–198.
    1. Das P, Horton R. Antibiotics: achieving the balance between access and excess. Lancet. 2016;387:102–104.
    1. Department of Health Making a fair contribution: a consultation on the extension of charging overseas visitors and migrants using the NHS in England. 2015.
    1. Kentikelenis A, Karanikolos M, Williams G. How do economic crises affect migrants' risk of infectious disease? A systematic-narrative review. Eur J Public Health. 2015;25:937–944.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다